Houston-based biotechnology startup Cemvita Factory has entered into an investment agreement with Occidental subsidiary Oxy Low Carbon Ventures (OLCV) to advance the development of innovative low-carbon technology. The investment will help Cemvita Factory develop new bio-engineered pathways that use CO2 as feedstock for sustainable intermediate chemicals and polymers production. Richard Jackson – president of OLCV […]
Ghana-based clothing manufacturer and exporter DTRT Apparel has received an undisclosed sum of investment from Red Bull and Verod Capital Management, registering a massive boost for apparel manufacturing in West Africa. Through a global network spanning three continents, DTRT Apparel procures textiles from Asia and supplies to major US-and EU-based brands. Skip Richmond – co-founder […]
Pro a Pro, a French food service distributor, has deployed the Zilliant Sales IQ platform, becoming the third company within the German multinational wholesaler METRO group to implement and utilize the sales technology. The platform is expected to help Pro a Pro make data-driven decision-making, enrich intelligent sales data and provide sellers with actionable guidance. […]
Alfasigma USA has launched ZELNORM (tegaserod) tablets in the US as a prescription drug for irritable bowel syndrome with constipation (IBS-C) in adult women aged under 65 years. ZELNORM was acquired by Alfasigma USA in July 2019 from Sloan Pharma, a subsidiary of US WorldMeds. Bryan Downey – president and CEO of Alfasigma USA said: “We […]
Rinvoq FDA approval : US biopharma company AbbVie has bagged approval from the US Food and Drug Administration (FDA) for its 15mg, daily once oral, small molecule Janus kinase (JAK) inhibitor – Rinvoq (upadacitinib) for the treatment of moderately to severely active rheumatoid arthritis (RA). The FDA approval for Rinvoq is for the treatment of […]
The post AbbVie secures Rinvoq FDA approval for rheumatoid arthritis appeared first on PharmaNewsDaily.com.
CVRx, a Maple Grove-based medical device company, has secured approval for its implantable technology – Barostim Neo System from the US Food and Drug Administration (FDA) to improve symptoms in patients with advanced heart failure. As per the FDA approval for the CVRx Barostim Neo System, the medical device has to be used in patients […]
The post FDA approves CVRx Barostim Neo System for advanced heart failure symptoms appeared first on PharmaNewsDaily.com.